The field of biochemical research thrives on the availability of precisely defined molecular tools. NINGBO INNO PHARMCHEM CO.,LTD. is proud to offer 2',3'-O-Isopropylideneadenosine (CAS 362-75-4), a compound that serves as a vital biochemical nucleoside for a wide array of research applications. Its high purity and specific chemical structure make it an invaluable asset for scientists investigating fundamental biological processes.

As a derivative of adenosine, 2',3'-O-Isopropylideneadenosine is instrumental in studies related to nucleoside metabolism, DNA and RNA synthesis, and enzyme kinetics. Researchers often utilize such intermediates to probe complex biological pathways, understand cellular mechanisms, and develop diagnostic tools or therapeutic agents. The reliability of this particular adenosine derivative is key to obtaining accurate and reproducible experimental results.

The crystalline powder form of 2',3'-O-Isopropylideneadenosine ensures ease of handling and accurate dosing in laboratory settings. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing researchers with materials that meet the highest standards of quality, thereby supporting breakthroughs in molecular biology, genetics, and pharmacology. The opportunity to buy this compound enables deeper exploration into cellular functions.

Beyond fundamental research, 2',3'-O-Isopropylideneadenosine also finds application as a pharmaceutical intermediate, contributing to the synthesis of more complex molecules with potential therapeutic benefits. Its versatility underscores its importance across different scientific disciplines. For those seeking essential biochemical reagents, this high purity adenosine derivative offers a dependable solution.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to advancing scientific discovery by providing critical chemical building blocks. We encourage researchers to explore the potential of 2',3'-O-Isopropylideneadenosine in their biochemical investigations, confident in its quality and utility for unlocking new insights into life sciences.